MedPath

TOBRADEX

TOBRADEX

Approved
DIN Number

00778915

Drug Class

Human

Market Date

Dec 31, 1990

Company
HC

novartis pharmaceuticals canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00778915
AIG Number0220325001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01CA01 DEXAMETHASONE AND ANTIINFECTIVES
Product Specifications
Dosage FormOintment
Route of AdministrationOphthalmic
AHFS Classification52:04.04
Health Canada Classification

ACTIVE INGREDIENTS (2)

DEXAMETHASONEActive
Strength: 0.1 % / W/W
Monograph: DEXAMETHASONE
TOBRAMYCINActive
Strength: 0.3 % / W/W
Monograph: TOBRAMYCIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.